RCMI 2021 | 14.01.01 - Thomas Maestri скачать в хорошем качестве

RCMI 2021 | 14.01.01 - Thomas Maestri

Abstract #14.01.01 — DESCRIPTION OF ANTIPSYCHOTIC PRESCRIBING BASED ON RACE Authors :: TJ MAESTRI; D Anderson; J Calderon-Abbo; M Echeverri ¬— Xavier University of Louisiana (TJM, DA, ME), Optum United Healthcare (JCA) PURPOSE: The hypothesis is that African Americans are being exposed to higher doses, and possibly inappropriate, antipsychotic therapy. Objectives of this study are to: (1) Describe the prescribing patterns of antipsychotic medications to patients from different racial backgrounds. (2) Explore appropriateness to therapy, as defined by FDA-labeling and avoidance of inappropriate polypharmacy. The goal is to describe baseline prescribing patterns for antipsychotics on the inpatient psychiatric setting to assess whether pharmacist intervention influences antipsychotic prescribing patterns in future studies. This could lead to clinical psychiatric pharmacist training programs directed at targeting healthcare disparities in mental illness. METHODS: This is a multi-centered, retrospective, chart review of 1000 patients admitted into inpatient behavioral health units and discharged having any psychotic diagnosis indicating a prescription for an antipsychotic or a long-acting formulation of an antipsychotic given prior to discharge. This study will describe antipsychotics prescribing patterns based on race, diagnosis, insurance coverage, and other socioeconomic factors. All data will be analyzed using the R statistical language, with Holm and Bonferroni multiple comparison corrections. Doses will be modeled using liner regression. EXPECTED RESULTS: Preliminary findings of this study from one site (n=400) showed that patients of involuntary admission status, past medication trials, a diagnosis of schizophrenia or bipolar disorder, and lack of family support had higher total daily doses of antipsychotics upon discharge. Inappropriate therapy was found most commonly with race, increasing age, and diagnosis of insomnia. CONCLUSION: Preliminary findings from the first site display a possible increase in inappropriate therapy in African American populations, though the expanded population from the second institution should further elucidate this result. This data will set the groundwork for future studies on the pharmacist role in addressing potential disparities in antipsychotic prescribing. Grant Support :: National Institutes of Health